The University of Chicago Header Logo

Connection

Mei-Yin Polley to Rituximab

Back to Details
This is a "connection" page, showing publications Mei-Yin Polley has written about Rituximab.
Mei-Yin Polley
Connection Strength
0.174
Rituximab
  1. Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial. Blood. 2020 06 18; 135(25):2224-2234.
    View in: PubMed
    Score: 0.174
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.